Deep brain stimulation—A new treatment approach in patients with multiple sclerosis

February 8, 2018, Charité - Universitätsmedizin Berlin

A pilot study conducted by researchers from Charité's NeuroCure Cluster of Excellence has shown that treatment with deep transcranial magnetic stimulation (dTMS) significantly reduces symptoms of fatigue in patients with multiple sclerosis (MS). Published in the current issue of the journal Neurology: Neuroimmunology & Neuroinflammation, results from this research suggest that TMS is a safe option for the treatment of patients with MS.

Up to 90 percent of people living with MS report experiencing severe fatigue. Fatigue can have a serious impact on both a person's work and social life, and leads many to give up work. In fact, a large percentage of people with MS rate fatigue as one of the most bothersome symptoms of the disease. Treatment options are scarce, and no licensed pharmaceutical treatments are available. In contrast, dTMS has been used in the diagnosis and of a range of neurological and psychiatric disorders.

A team of researchers led by Prof. Dr. Friedemann Paul of the NeuroCure Clinical Research Center (NCRC) has shown that dTMS, using the proprietary H-coil, a technology that allows brain stimulation three times deeper than that of standard TMS, is capable of producing significant improvements in fatigue symptoms. The severity of MS-associated symptoms was assessed using a standardized questionnaire and the Fatigue Severity Scale (FSS). 33 study participants with fatigue received thrice-weekly sessions of dTMS for a duration of six weeks; this involves a stimulation H-coil being placed above the patient's head, which generates a magnetic field that influences nerve activity and neural circuits in the brain. A control group received a sham treatment.

"We observed no serious side effects in patients treated with dTMS, and it is therefore worth stressing the tolerability of this noninvasive electrophysiological technique," says Prof. Paul, the study's principal investigator. Further, it is also worth noting that the treatment was delivered using a new type of H-coil, which had been developed specifically for use in this study. This coil permits the targeted stimulation of areas of the brain which, according to the latest research, play a major role in MS-associated fatigue. A follow-up study involving a larger number of participants is being planned. This is intended to verify the efficacy of this treatment method, and to help ensure the implementation of dTMS for MS-associated fatigue into routine clinical practice. "We are excited about the collaboration between Prof. Dr. Friedemann Paul and his team at Charité's NeuroCure and Brainsway for studying the use of our patented Deep TMS technology for the benefit of MS patients, a new neurological field for us. These promising results of relieving the very hard to treat symptoms in MS, brings a new hope for being able to provide a solution for the many patients who need it." Says Ronen Segal, CTO of Brainsway LTD.

Explore further: Deep brain stimulation for the treatment of movement disorders

More information: Gunnar Gaede et al, Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue, Neurology - Neuroimmunology Neuroinflammation (2017). DOI: 10.1212/nxi.0000000000000423

Related Stories

Deep brain stimulation for the treatment of movement disorders

December 27, 2017
For the first time, researchers from Charité have shown that in patients with a type of movement disorder known as dystonia, a particular pattern of brain activity is linked to both the severity of symptoms and the clinical ...

Transcranial direct current stimulation reduces fatigue associated with multiple sclerosis

October 2, 2017
People with multiple sclerosis (MS) who underwent a non-invasive form of electrical brain stimulation experienced significant reductions in fatigue, a common and often debilitating symptom of the disease, according to new ...

Magnetic brain stimulation causes weight loss by making gut bacteria healthier

April 3, 2017
A new study finds that a noninvasive electromagnetic brain stimulation technique helps obese people lose weight, partly by changing the composition of their intestinal bacteria—the so-called gut microbiota. Results of the ...

Anakinra ineffective for reducing symptoms of chronic fatigue

March 8, 2017
(HealthDay)—The anti-inflammatory biologic drug anakinra (Kineret) does not reduce fatigue severity in women with chronic fatigue syndrome, according to a study published online March 7 in the Annals of Internal Medicine.

How chronic fatigue syndrome wears patients out

July 28, 2017
(HealthDay)—Imagine if your muscles kept telling your brain you were exhausted, even when you were resting.

Multidisciplinary rehab tops CBT for chronic fatigue syndrome

August 31, 2015
(HealthDay)—For patients with chronic fatigue syndrome (CFS), multidisciplinary rehabilitation treatment (MRT) is more effective for reducing fatigue than cognitive behavioral therapy (CBT), according to a study published ...

Recommended for you

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

A 15-minute scan could help diagnose brain damage in newborns

November 14, 2018
A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

New brain imaging research shows that when we expect something to hurt it does, even if the stimulus isn't so painful

November 14, 2018
Expect a shot to hurt and it probably will, even if the needle poke isn't really so painful. Brace for a second shot and you'll likely flinch again, even though—second time around—you should know better.

New clues to the origin and progression of multiple sclerosis

November 13, 2018
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The ...

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

In live brain function, researchers are finally seeing red

November 12, 2018
For years, green has been the most reliable hue for live brain imaging, but after using a new high-throughput screening method, researchers at the John B. Pierce Laboratory and the Yale School of Medicine, together with collaborators ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.